New Companies I’m Excited About
Two new biotech companies are in development to treat diseases and help patients in a profoundly impactful way.
New Companies I’m Excited About Read More »
Two new biotech companies are in development to treat diseases and help patients in a profoundly impactful way.
New Companies I’m Excited About Read More »
Collaboration across government agencies, industry, academia, care delivery systems, foundations, philanthropists and patients and across national boundaries is needed to overcome highly lethal cancers, regional and socioeconomic differences in cancer outcomes and inefficiencies in clinical trials and their high failure rates.
Why Collaboration is Key Read More »
This has been a very special year of transition and new initiatives. My core mission continues to be ending cancer. Serving six years as president at MD Anderson is one of the great honors of my life. I remain at MD Anderson pursuing science in my lab, helping patients and serving the institution. I am
Here’s What I’m Working On Read More »
Metabolic reprograming is an emerging hallmark of tumor biology and an actively pursued opportunity in discovery of oncology drugs. Extensive efforts have focused on therapeutic targeting of glycolysis, whereas drugging mitochondrial oxidative phosphorylation (OXPHOS) has remained largely unexplored, partly owing to an incomplete understanding of tumor contexts in which OXPHOS is essential. Here, we report
An Inhibitor of Oxidative Phosphorylation Exploits Cancer Vulnerability Read More »
Recognizing that vaccination rates for the human papillomavirus (HPV) remain low across the U.S., particularly in Texas, The University of Texas MD Anderson Cancer Center again has joined with the 69 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to call for increased HPV vaccination and evidence-based screening, with the goal
Scott Courville admired his full beard and round belly in the mirror: He was ready for the upcoming holiday season. It was November 2015 and Courville, who plays Santa Claus in Lafayette, Louisiana, was too excited about his favorite time of year to worry much about the pain developing in his jaw. By February, though,
The Rise of HPV-Related Cancers in Men Read More »
Most women with early-stage breast cancer may be able to avoid chemotherapy, a new study finds. Researchers determined that patients with smaller-sized tumors that had not spread to the lymph nodes did just as well without chemo as those who got the treatment, according to the study presented Sunday at the American Society of Clinical
Many women with early breast cancer may not need chemo, study finds Read More »
Recently, Mayor Sylvester Turner recognized the contributions of Ronald A. DePinho, M.D. to our community and the world at a City Hall ceremony. I have since learned more about the person and leader that inspired the Mayor’s Proclamation. Ron is an internationally renowned physician-scientist whose name is often associated with significant scientific discoveries in the
Physician Scientist with a Lifelong Devotion to Reduce Cancer Suffering Read More »
If you’re well past the age of 12, you’re probably not spending too much time thinking about HPV—you got the vaccine or you didn’t, so you’re either safe or not, right? Not so fast—an HPV vaccine isn’t a “get out of jail free” card, just like an HPV diagnosis isn’t a death sentence for your
Literally Everything You Need to Know About HPV Read More »
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report
HPV vaccines prevent cervical cancer, global review confirms Read More »